November 21, 2017
Symcel secures €3.572 million
Symcel has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 20, 2017
Oxford Pharmascience step closer to MAA in sweden for OXPzero Ibuprofen containing OTC
Oxford Pharmascience has received scientific advice from the MPA (Swedish regulatory authority) about the development programme for future marketing authorisation…
November 20, 2017
EC approves Novartis’s Tasigna
The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…
November 16, 2017
Pneumonia in babies, prevention
Pneumonia represents a significant health risk in the very young and very old, and mortality rates remain high among the…
November 15, 2017
FDA OK’s AstraZeneca’s breast cancer drug
US Food and Drug Administration (FDA) has approved a new indication for AstraZeneca’s Faslodex(fulvestrant), expanding the indication to include use with…
November 15, 2017
Cardinal Health sells it’s China business to Shanghai Pharmaceuticals for $1.2B
Cardinal Health will sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding for $1.2 billion.
November 14, 2017
Hikma buys 6 Boehringer’s products
Hikma Pharmaceuticals has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim).
November 14, 2017
Novartis to present new data about broad range of breast cancer
Novartis announced it would present data across its breast cancer portfolio and pipeline in a broad range of patient populations,…
November 14, 2017
Beximco increases comprehensive net income in Q1 2017, ships second product to US
Beximco Pharmaceuticals last week started the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US.
November 14, 2017
Pertinax Pharma appoints ex Sanofi man as new chairman to deal with newly launched Pertinax
Pertinax Pharma has appointed Nigel Brooksby as chairman of the company. His main task will be the commercialisation of Pertinax,…